Viridian Therapeutics (NasdaqCM:VRDN) 2025 Conference November 12, 2025 09:20 AM ET Company ParticipantsShan Wu - Chief Business OfficerSteve Mahoney - CEOTony Castianos - Chief Commercial OfficerConference Call ParticipantsAlex Thompson - Biotech AnalystAlex ThompsonGood morning, everyone. I'm Alex Thompson, a biotech analyst here at Stifel. Happy to have the Viridian Therapeutics team here with us this morning: Steve Mahoney, CEO, Tony Castianos, Chief Commercial Officer, and Shan Wu, Chief Business Offic ...